|
Volumn 97, Issue 21, 2005, Pages 1620-1622
|
Re: Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes in optimally debulked advanced ovarian cancer: A randomized clinical trial (multiple letters) [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADVANCED CANCER;
BLOOD TRANSFUSION;
CANCER CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CYSTIC LYMPHANGIOMA;
CYTOREDUCTIVE SURGERY;
HOSPITALIZATION;
HUMAN;
INTERMETHOD COMPARISON;
LETTER;
LYMPH NODE DISSECTION;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
LYMPHEDEMA;
OVARY CANCER;
PARAAORTIC LYMPH NODE;
PELVIS LYMPH NODE;
POSTOPERATIVE COMPLICATION;
POSTOPERATIVE HEMORRHAGE;
PRIORITY JOURNAL;
PROGNOSIS;
QUALITY OF LIFE;
RANDOMIZATION;
RISK BENEFIT ANALYSIS;
SURGICAL TECHNIQUE;
AORTA;
FEMALE;
HUMANS;
LYMPH NODE EXCISION;
LYMPHATIC METASTASIS;
LYMPHEDEMA;
OVARIAN NEOPLASMS;
PELVIS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 27944475969
PISSN: 00278874
EISSN: 14602105
Source Type: Journal
DOI: 10.1093/jnci/dji347 Document Type: Letter |
Times cited : (5)
|
References (0)
|